Governors Lane Lp Lowers stake in HeartWare International Inc (HTWR)

HeartWare International Inc (HTWR) : Governors Lane Lp reduced its stake in HeartWare International Inc by 2.04% during the most recent quarter end. The investment management company now holds a total of 96,000 shares of HeartWare International Inc which is valued at $5,562,240 after selling 2,000 shares in HeartWare International Inc , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.HeartWare International Inc makes up approximately 0.83% of Governors Lane Lp’s portfolio.

Other Hedge Funds, Including , Capital World Investors reduced its stake in HTWR by selling 356,100 shares or 44.56% in the most recent quarter. The Hedge Fund company now holds 443,000 shares of HTWR which is valued at $25,667,420. HeartWare International Inc makes up approx 0.01% of Capital World Investors’s portfolio.Citadel Advisors reduced its stake in HTWR by selling 26,569 shares or 65.61% in the most recent quarter. The Hedge Fund company now holds 13,927 shares of HTWR which is valued at $806,930.Blackrock Institutional Trust Company N.a. reduced its stake in HTWR by selling 3,801 shares or 0.85% in the most recent quarter. The Hedge Fund company now holds 443,698 shares of HTWR which is valued at $25,707,862.First Mercantile Trust Co reduced its stake in HTWR by selling 2,233 shares or 20.27% in the most recent quarter. The Hedge Fund company now holds 8,782 shares of HTWR which is valued at $508,829. HeartWare International Inc makes up approx 0.06% of First Mercantile Trust Co’s portfolio.

On the company’s financial health, HeartWare International Inc reported $-0.62 EPS for the quarter, beating the analyst consensus estimate by $ 0.19 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $-0.81. The company had revenue of $68.72 million for the quarter, compared to analysts expectations of $57.36 million. The company’s revenue was down -6.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $-0.47 EPS.

Many Wall Street Analysts have commented on HeartWare International Inc. HeartWare International Inc was Downgraded by Raymond James to ” Mkt Perform” on Jul 13, 2016. HeartWare International Inc was Downgraded by Leerink Partners to ” Mkt Perform” on Jul 11, 2016. HeartWare International Inc was Downgraded by Wells Fargo to ” Market Perform” on Jun 29, 2016.

Heartware International Inc. is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices for patients suffering from advanced heart failure. The HeartWare Ventricular Assist System (HVAD System) which includes a ventricular assist device (VAD) or blood pump patient accessories and surgical tools provides circulatory support for patients in the advanced stage of heart failure. The core of the HVAD System is a continuous flow blood pump the HVAD pump. The HVAD System is designed to be implanted adjacent to the heart avoiding abdominal surgery directly adjacent to the heart. The Company’s hybrid system is used for suspending the impeller. The impeller is suspended within the pump housing by the opposing forces of passive magnets and hydrodynamic thrust generated by the pump impeller which circulates a cushion of blood.

Leave a Reply

HeartWare International Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on HeartWare International Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.